⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27669543 | 0.82 | HTT (0.33) | — | |
| SCHEMBL18227158 | 0.78 | — | — | |
| SCHEMBL3150633 | 0.78 | — | — | |
| SCHEMBL11316033 | 0.75 | — | — | |
| SCHEMBL252925 | 0.73 | HTT (0.35) | — | |
| SCHEMBL7559774 | 0.73 | HTT (0.35) | — | |
| SCHEMBL4715987 | 0.72 | — | — | |
| SCHEMBL10720112 | 0.72 | TSHR (0.42) | — | |
| SCHEMBL11970000 | 0.70 | HTT (0.42) | — | |
| SCHEMBL21609601 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1700922-B1 | 3-Substituted 5-Nitroindole derivatives and labeled oligonucleotide probes containing them | ROCHE DIAGNOSTICS GMBH (DE) | 2016-08-24 | — | — | EP | claimed |
| EP-2266958-A1 | Antiviral agent | SHIONOGI & CO., LTD. (JP) | 2010-12-29 | — | — | EP | claimed |
| US-7695980-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2010-04-13 | — | — | US | claimed |
| EP-1646609-B1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-14 | — | — | EP | claimed |
| US-7563902-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2009-07-21 | — | — | US | claimed |
| US-20060199833-A1 | Novel chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-07 | — | — | US | claimed |
| US-20060199223-A1 | storage stability; immunoassays | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-07 | — | — | US | claimed |
| US-20060172358-A1 | Novel chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-08-03 | — | — | US | claimed |
| EP-1149069-A1 | PHENYLGLYCINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | claimed |
| WO-2000035858-A1 | PHENYLGLYCINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | claimed |
| EP-0593452-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1994-04-27 | — | — | EP | claimed |
| EP-0593452-A4 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN. | MALLINCKRODT MEDICAL INC (US) | 1992-08-31 | — | — | EP | claimed |
| WO-1991007991-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1991-06-13 | — | — | WO | claimed |
| EP-3060545-B1 | METHOD FOR SYNTHESISING A MERCAPTAN BY ADDING HYDROGEN SULPHIDE TO AN OLEFIN | ARKEMA FRANCE (FR) | 2020-09-23 | — | — | EP | disclosed |
| US-9663461-B2 | Method for synthesising a mercaptan by adding hydrogen sulfide to an olefin | ARKEMA FRANCE (FR) | 2017-05-30 | — | — | US | disclosed |
| US-20160257646-A1 | METHOD FOR SYNTHESISING A MERCAPTAN BY ADDING HYDROGEN SULFIDE TO AN OLEFIN | ARKEMA FRANCE (FR) | 2016-09-08 | — | — | US | disclosed |
| WO-2000035858-A1 | PHENYLGLYCINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| EP-0593452-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1994-04-27 | — | — | EP | disclosed |
| EP-0593452-A4 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN. | MALLINCKRODT MEDICAL INC (US) | 1992-08-31 | — | — | EP | disclosed |
| WO-1991007991-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1991-06-13 | — | — | WO | disclosed |